Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07354139 · ClinicalTrials.gov registry record · NA

Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter

A NA study, sponsored by The University of Texas at Dallas.

Recruiting
Registry status
NA
Development phase
50
Enrollment target

NCT07354139: Recruiting NA study, sponsored by The University of Texas at Dallas.

NCT07354139 is a NA study that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07354139, a NA study, is actively recruiting participants, sponsored by The University of Texas at Dallas.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this study is to find out whether a type of noninvasive brain stimulation can help reduce speech errors, such as repetitions, blocks, and prolongations, in people who stutter. This pilot study will help researchers design future treatments to see if targeting certain brain areas can improve speech fluency. The study will look at how people speak and behave during both speaking and non-speaking tasks before and after the brain stimulation. Participants will complete an online survey about 24 hours before coming to the clinic. The clinic visit will last about 3 hours and will include three phases. All parts of the study will be audio-recorded. 1. Pre-Testing: Participants will first complete a stuttering evaluation to determine whether they are typical speakers or have a mild, moderate, or severe stutter. Then, they will do several speaking and non-speaking tasks. 2. Brain Stimulation: Participants will receive a session of targeted noninvasive brain stimulation (HD-tDCS). 3. Post-Testing: After the brain stimulation, participants will repeat the same evaluation and tasks they completed during pre-testing. Brain stimulation description: HD-tDCS is a non-invasive technique that requires the placement of several sensors (metal electrodes) on a special cap and saline gel on your head. Very low levels of constant electrical current are delivered to specifically targeted areas of the brain via these electrodes. You may experience a slight feeling of dizziness when starting the stimulation. This occurs in a small number of subjects. This takes only a few seconds and does not affect balance after the stimulation has been completed. Several research centers have previously investigated the use of this device on healthy subjects and have found the device to be safe with no direct effect on the person's well-being. Following stimulation, participants will have the opportunity to rinse out residual gel from hair and scalp.

Primary Outcome

Stuttering Severity Instrument-Fourth Edition (SSI-4) is a reliable and valid norm-referenced stuttering assessment that can be used for both clinical and research purposes. It measures stuttering severity in both children and adults in the four areas of speech behavior: frequency duration physical concomitants naturalness of the individual's speech. The SSI-4 scores stuttering severity by combining measures of frequency (% syllables stuttered), duration (length of longest stutters), and physi

Interventions

  • DEVICE High - Definition Transcranial Direct Current Stimulation

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-03-17
Est. Completion 2026-09-30
Phase NA
The University of Texas at Dallas

50 total trials

What NCT07354139 shows while recruiting

NCT07354139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which High - Definition Transcranial Direct Current Stimulation is the first listed.

NCT07354139 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07354139 about?

NCT07354139 is a clinical study titled "Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter". The goal of this study is to find out whether a type of noninvasive brain stimulation can help reduce speech errors, such as repetitions, blocks, and prolongations, in people who stutter. This pilot study will help researchers design future treatments to see if targeting certain brain areas can impr...

What is the current status of trial NCT07354139?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-17. Estimated completion is 2026-09-30.

What interventions are being tested in trial NCT07354139?

The interventions under investigation include: High - Definition Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07354139?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07354139's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07354139, the US trial registry maintained by the National Library of Medicine. NCT07354139 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.